Writing the Future of Cell Therapies using the Twist Biopharma Library of Libraries
Time: 11:15 am
day: Day 2 - Track A - Morning
Details:
- Utilising its proprietary DNA technology to write synthetic libraries, Twist Biopharma provides end-to-end antibody and TCR discovery libraries including both
(1) highly diverse synthetic naïve scFv and VHH antibody phage display libraries to discover targeting domains for CAR-T constructs, and
(2) combinatorically assembled TCR libraries from gene fragments - In this talk, Aaron Sato, CSO, will present several POC data on how these technologies can be utilised for cell therapies
